CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 240 filers reported holding CONMED CORP in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,906 | +18.3% | 105 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $9,219 | +207.3% | 104 | +173.7% | 0.00% | – |
| Q3 2022 | $3,000 | -75.0% | 38 | -70.3% | 0.00% | -100.0% |
| Q2 2022 | $12,000 | -42.9% | 128 | -12.9% | 0.00% | -33.3% |
| Q1 2022 | $21,000 | +5.0% | 147 | +2.8% | 0.00% | 0.0% |
| Q4 2021 | $20,000 | +33.3% | 143 | +27.7% | 0.00% | +50.0% |
| Q3 2021 | $15,000 | -11.8% | 112 | -8.2% | 0.00% | -33.3% |
| Q2 2021 | $17,000 | +30.8% | 122 | +22.0% | 0.00% | -50.0% |
| Q1 2021 | $13,000 | +30.0% | 100 | +11.1% | 0.01% | +50.0% |
| Q4 2020 | $10,000 | +150.0% | 90 | +66.7% | 0.00% | +100.0% |
| Q3 2020 | $4,000 | +33.3% | 54 | +45.9% | 0.00% | +100.0% |
| Q2 2020 | $3,000 | +200.0% | 37 | +48.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 25 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $2,000 | – | 25 | +316.7% | 0.00% | – |
| Q4 2018 | $0 | – | 6 | +20.0% | 0.00% | – |
| Q3 2018 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
| Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
| Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
| Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
| EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
| Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
| MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
| Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
| EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |